Are Mental Health Services Losing Out in the US Under Managed Care? Dale L. Johnson Current Opinion 03 December 2012 Pages: 597 - 601
Thrombolysis, Stroke Units and Other Strategies for Reducing Acute Stroke Costs Theodore H. WeinSusan L. HickenbottomAndrei V. Alexandrov Leading Article 03 December 2012 Pages: 603 - 611
A Review of Quality of Life in Alzheimer’s Disease Sam S. SalekMelvyn D. WalkerAntony J. Bayer Review Article 03 December 2012 Pages: 613 - 627
Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption Hind T. HatoumSheldon X. KongWallace B. Mendelson Original Research Article 03 December 2012 Pages: 629 - 637
The Use and Cost of HIV Service Provision in England in 1996 Eduard J. BeckKeith TolleyIan Williams Original Research Article 03 December 2012 Pages: 639 - 652
Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction Peter K. SchädlichEduard HuppertzJosef Georg Brecht Original Research Article 03 December 2012 Pages: 653 - 669
Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma Maureen P. M. H. Rutten-van MölkenEddy K. A. van DoorslaerM. Denise Till Original Research Article 03 December 2012 Pages: 671 - 684
Fosphenytoin Stephen M. HollidayPaul BenfieldGreg L. Plosker Adis Formulary Perspective 03 December 2012 Pages: 685 - 690
Cyclosporin Microemulsion (Neoral®)† Allan J. CoukellGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 03 December 2012 Pages: 691 - 708
A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe Linda D. MacKeigan Correspondence 03 December 2012 Pages: 709 - 709
The authors reply Sheila HoodLieven AnnemansMaureen Rutten-van Mölken Correspondence 03 December 2012 Pages: 710 - 711
Common Errors and Controversies in Pharmacoeconomic Analyses Javier Soto Correspondence 03 December 2012 Pages: 711 - 712